MotivationProtein solubility is an important property in industrial and therapeutic applications. Prediction is a challenge, despite a growing understanding of the relevant physicochemical properties.ResultsProtein–Sol is a web server for predicting protein solubility. Using available data for Escherichia coli protein solubility in a cell-free expression system, 35 sequence-based properties are calculated. Feature weights are determined from separation of low and high solubility subsets. The model returns a predicted solubility and an indication of the features which deviate most from average values. Two other properties are profiled in windowed calculation along the sequence: fold propensity, and net segment charge. The utility of these additional features is demonstrated with the example of thioredoxin.Availability and implementationThe Protein–Sol webserver is available at http://protein-sol.manchester.ac.uk.
Prediction and engineering of protein
solubility is an important
but imprecise area. While some features are routinely used, such as
the avoidance of extensive non-polar surface area, scope remains for
benchmarking of sequence and structural features with experimental
data. We study properties in the context of experimental solubilities,
protein gene expression levels, and families of abundant proteins
(serum albumin and myoglobin) and their less abundant paralogues.
A common feature that emerges for proteins with elevated solubility
and at higher expression and abundance levels is an increased ratio
of lysine content to arginine content. We suggest that the same properties
of arginine that give rise to its recorded propensity for specific
interaction surfaces also lead to favorable interactions at nonspecific
contacts, and thus lysine is favored for proteins at relatively high
concentration. A survey of protein therapeutics shows that a significant
subset possesses a relatively low lysine to arginine ratio, and therefore
may not be favored for high protein concentration. We conclude that
modulation of lysine and arginine content could prove a useful and
relatively simple addition to the toolkit available for engineering
protein solubility in biotechnological applications.
Background: Vitamin D is beneficial in human and experimental chronic kidney disease, the leading cause of which is diabetic nephropathy. Vitamin D through its receptor, VDR, provides renal protection in diabetic nephropathy, but limited data exist about its effect on podocytes. Renal podocytes form the main filtration barrier possessing a unique phenotype maintained by proteins including podocalyxin and nephrin, the expression of which is suppressed in pathological conditions. Methods: We used immortalized human podocytes (human glomerular epithelial cells, HGEC) to assess podocalyxin and nephrin expression after treatment with 1,25-dihydroxyvitamin D3 (calcitriol) and its analogue paricalcitol. The involvement of VDR was investigated by silencing with hVDR-siRNA and ChIP analysis. Results: HGEC exhibit high glucose-mediated downregulation of podocalyxin and nephrin, loss of which has been linked with loss of the permselective renal barrier and proteinuria. Calcitriol and paricalcitol reversed high glucose-induced decrease of nephrin and significantly enhanced podocalyxin expression in podocytes cultured in high glucose. HGEC express VDR and retinoid X receptor (RXR). In the presence of calcitriol and paricalcitol, VDR expression was upregulated and VDR colocalized with RXR in the nucleus. VDR knockdown abolished the protective action of calcitriol and paricalcitol on podocalyxin expression indicating that podocalyxin activation of expression is partly mediated by VDR. Furthermore, VDR specifically regulates podocalyxin expression by bounding to a site upstream of the podocalyxin promoter. Conclusion: Vitamin D analogues maintain and, furthermore, re-activate the expression of specialized components of podocytes including podocalyxin, hence they provide protection against loss of the permselective renal barrier, with molecular mechanisms elucidated herein.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.